EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -1.381
March 31, 2026 -7.09
December 31, 2025 -7.529
September 30, 2025 -9.808
June 30, 2025 -8.766
March 31, 2025 -3124.56
December 31, 2024 -8248.35
September 30, 2024 -899.82
June 30, 2024 -1124.78
March 31, 2024 -13647.27
December 31, 2023 -38977.20
September 30, 2023 -67336.53
June 30, 2023 -200359.9
March 31, 2023 -629874.0
December 31, 2022 -794841.0
September 30, 2022 -3.194M
June 30, 2022 -7.888M
March 31, 2022 -15.82M
December 31, 2021 -27.13M
September 30, 2021 -33.46M
June 30, 2021 -124.93M
March 31, 2021 -181.43M
December 31, 2020 -672.14M
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Immutep Ltd. --
CSL Ltd. --
Ceryvyn Therapeutics Ltd. --
Mesoblast Ltd. --
Actinogen Medical Ltd. --

EPS Diluted (Quarterly) Related Metrics